Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins(Fribourg Development Agency), Michel Obéid(University of Lausanne)
Cited by 2,213
Related Papers
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy
|Annals of Oncology|2020|230
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy
|Journal for ImmunoTherapy of Cancer|2020|164
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
|European Heart Journal|2025|34